SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-031799
Filing Date
2021-06-04
Accepted
2021-06-04 16:35:17
Documents
7
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20210604.htm 6-K 25680
2 EX-99.1 lmnl-ex991_6.htm EX-99.1 58441
3 EX-99.2 lmnl-ex992_7.htm EX-99.2 64087
4 EX-99.3 lmnl-ex993_8.htm EX-99.3 38416
5 GRAPHIC g2y4de2u53dz000001.jpg GRAPHIC 38195
6 GRAPHIC g0nox3xd4wqx000001.jpg GRAPHIC 2579
7 GRAPHIC gvz2yywb12sc000001.jpg GRAPHIC 38195
  Complete submission text file 0001564590-21-031799.txt   296905
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 21996967
SIC: 2834 Pharmaceutical Preparations